
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Sparassis crispa dual extract contains beta-glucans and other bioactive polysaccharides that enhance immune system function through natural killer cell activation. These compounds work by modulating immune cell signaling pathways to improve the body's defense against pathogens and oxidative stress.

Reported Benefits (Provisional)
Origin & History

Sparassis crispa, also known as the cauliflower mushroom, is found in temperate forests of Asia, Europe, and North America. The dual extract combines both water and alcohol extraction methods to maximize bioactive compounds.
Research Narrative (Provisional)
Research suggests that Sparassis crispa may enhance immune function and have potential anti-diabetic effects. Further studies are needed to validate these benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Rich in beta-glucans. - Contains antioxidants. - High in polysaccharides. - Low in calories and fat.
Reported Mechanism (Provisional)
Sparassis crispa's beta-glucans bind to dectin-1 and complement receptor 3 on immune cells, triggering downstream signaling cascades that activate natural killer cells and macrophages. The polysaccharide compounds also stimulate cytokine production, particularly interferon-gamma and interleukin-12, which coordinate immune responses. Additionally, the extract's antioxidant compounds neutralize reactive oxygen species through direct scavenging and upregulation of endogenous antioxidant enzymes.
Clinical Narrative (Provisional)
Clinical evidence for Sparassis crispa is primarily based on in vitro and animal studies demonstrating immune enhancement effects. Human trials are limited, with small pilot studies showing potential immune biomarker improvements in healthy adults. The 40% increase in immune defense mentioned appears to be derived from laboratory studies measuring natural killer cell activity rather than large-scale human clinical trials. More robust human studies with larger sample sizes and longer durations are needed to confirm therapeutic benefits and establish optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







